chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe arm, neck and shoulder pain within 5 hours of injection. Pain unbearable for first two dayUnrelieved by ibuprofen, acetaminophen, ice or heat and continuing through day 12 after injection. Diagnosed with bursitis on 10/25/2023. Unable to sleep, lift anything with right arm, or swim which is the patient's primary form of exercise.
PFIZER-BIONTECH COVID-19 VACCINE EUA.  ADMINISTRATION ERROR:  It has been discovered that patient received 2nd dose of Covid-19 vaccine too early.  The 1st and 2nd doses are recorded to be given 7 days apart at 2 different nursing facilities.  The patient received the 1st dose on 1/4/21 at a nursing facility.  On 1/11, the patient received a dose at the nursing facility.  Consent form stated no prior doses received.  No adverse events have been reported.
11/5/2022-Presents to ED via EMS "I have pneumonia".  ABG-7.452/44/55/30.3/ 88% 6L. Acute hypoxic rsp failure s/t covid. Covid + test. HX copd chronic 02 dep. Trop neg. D Dimer-248. WBC-12 CRP 22.5 Start decadron, inhalers. K-3.0 potassium 10 Meq x 5 doses given. Heparin. CXR-small b/l plueral effusion. VSS, 02 93%. Remdesivir started.  11/7/2022- 3L NC 02 sat low 90's.  11/11/2022- Doxy,Flagyl and  mucinex ordered. Chest Ct possible spiration L upper lobe. Pt refused ABG's Productive cough On 15L nRB up from 3L , desat to 73%  now 94%.  11/12/2022-WBC-17.4 Continue Doxy and Fagyl additional 5 days  11/15/2022-Titrate o2 to 2l NC.  11/16/2022-On dexamethasone, finished remdisivir. Chronic SOb d/t copd. Improved. WBC 15.0. Follow up with PCP  d/c to SNF,
Increase swelling redness of (R) upper arm. No c/o pain. Patient praying with other siblings.
Suspected vaccination failure; have had them 3 times; very painful; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles three times and it was very painful. The patient would get vaccinated again. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
No additional AEs were reported; unknown number of patients receive improperly stored vaccines; This spontaneous report was received from a nurse referring to multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history, concurrent conditions, previous drug allergies or reactions, and concomitant medications were not reported.  Since 23-SEP-2021, the patients were vaccinated with improperly stored vaccines (product storage error) as varicella virus vaccine live (oka/merck)(VARIVAX) and measles (+) mumps(+) rubella (+) varicella (oka-merck) virus vaccine live (PROQUAD) for prophylaxis  (strength, dose, anatomical location, route of administration, lot #, and expiration date were not reported).  The doses of varicella virus vaccine live (oka/merck)(VARIVAX) and measles (+) mumps(+) rubella (+) varicella (oka-merck) virus vaccine live (PROQUAD) were exposed to a temperature excursion of -14.4 degrees Celsius (°C) during a time frame of 7 minutes. There was no prior temperature excursion and no adverse events were reported.
Rash.  Papular, non-itchy, confluent, non-inflamed trunk, face and extremeties, not the palms of hands.  Posterior cervical adenopothies.  Afebrile, no cough, no coryza.
Information has been received from a certified medical assistant concerning a white male with diabetes and hyperlipidemia who on 06-SEP-2007 was vaccinated SC on right arm with a dose of Zostavax (Oka/Merck) (Lot #656858/0356U).  On 13-SEP-2007 the patient experienced shingles on face.  Unspecified medical attention was sought.  A product quality complaint was not involved.  Additional information has been received from the certified medical assistant who stated that patient developed significant herpes zoster on left side of his face.  On an unspecified date the patient had recovered.  No further information is expected.
Feels sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (unknown if pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 17Mar2021 (Batch/Lot number: unknown) at the age of 41 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious) with onset 18Mar2021, outcome "unknown", described as "Feels sick". It was unknown if therapeutic measures were taken as a result of illness.  Additional information: it was unknown if other vaccine in four weeks, if covid prior vaccination and if covid tested post vaccination. It was added that the patient Feels sick, out of work.  No follow-up attempts are possible. No further information is expected.
I started having difficulty walking, talking and swallowing. About a week later started having motor skills with my hands. This all hours of the day until I got IVIG  now partial hours of the day. It was not until recently my symptoms started to subside. I have had to increase my medications.
Patient given expired Pfizer Covid Vaccination 5 days after expiration date.  No Adverse Reactions reported.  No treatments given.
VACCINE WAS ADMINISTERED PAST THE RECOMMENDED STORAGE TIME (VACCINE WAS REFRIGERATED OVER NIGHT BEFORE BEING ADMINISTERED); This spontaneous report received from a health care professional concerned a 29 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811, and expiry: 20-MAR-2022) dose was not reported, administered on 26-OCT-2021 10:40 for prophylactic vaccination. No concomitant medications were reported. On 26-OCT-2021, the patient experienced vaccine was administered past the recommended storage time (vaccine was refrigerated over night before being administered). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccine was administered past the recommended storage time (vaccine was refrigerated over night before being administered) was not reported. This report was non-serious. This case, from the same reporter is linked to 20211052091.
left upper arm edema and axillary edema. tender to touch and warm to touch. limited rom of left arm
Fever for 36+ hours. Reached high of 104.4 the second night after vaccination. No appetite. Nighttime incontinence during the high fever night. Fever is controlled by alternating acetaminophen and ibuprofen, but it hasn?t been down lower than 100 for more than an hour at a time.
productive cough but no fever; difficult breathing; Chest pain; Fatigue/tired all day; balance problem; left foot plantar fascia pain; headache on top of head; puffy face; explosive bowel movement; abdomen feels like it's burning; burning of anus; Sore shoulder after second dose; temperature increase; General malaise; clearing throat; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore shoulder after second dose), PYREXIA (temperature increase), MALAISE (General malaise), THROAT IRRITATION (clearing throat) and ABDOMINAL DISCOMFORT (abdomen feels like it's burning) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history is provided by reporter.  Concomitant products included LEVOTHYROXINE, THYROID (ARMOUR THYROID) and KETOCONAZOLE for an unknown indication.    On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced ARTHRALGIA (Sore shoulder after second dose), PYREXIA (temperature increase), MALAISE (General malaise) and THROAT IRRITATION (clearing throat). On 10-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (abdomen feels like it's burning), ANORECTAL DISCOMFORT (burning of anus) and DIARRHOEA (explosive bowel movement). On 12-Mar-2021, the patient experienced HEADACHE (headache on top of head) and SKIN SWELLING (puffy face). On 04-Apr-2021, the patient experienced CHEST PAIN (Chest pain), FATIGUE (Fatigue/tired all day), BALANCE DISORDER (balance problem), PLANTAR FASCIITIS (left foot plantar fascia pain) and DYSPNOEA (difficult breathing). On 08-Apr-2021, the patient experienced COUGH (productive cough but no fever). On 08-Mar-2021, PYREXIA (temperature increase) and MALAISE (General malaise) had resolved. On 04-Apr-2021, CHEST PAIN (Chest pain) and FATIGUE (Fatigue/tired all day) was resolving. At the time of the report, ARTHRALGIA (Sore shoulder after second dose) had resolved, THROAT IRRITATION (clearing throat), ABDOMINAL DISCOMFORT (abdomen feels like it's burning), ANORECTAL DISCOMFORT (burning of anus), HEADACHE (headache on top of head), SKIN SWELLING (puffy face), DIARRHOEA (explosive bowel movement) and DYSPNOEA (difficult breathing) outcome was unknown and PLANTAR FASCIITIS (left foot plantar fascia pain) and COUGH (productive cough but no fever) was resolving. Not Provided          On 07-MAR-2021 Patient had received second dose of Moderna COVID-19 Vaccine. On 07-MAR-2021 Patient felt spacey, sluggish, really off, made mistakes on things that she normally avoid or would not do and not function well   This case was linked to US-MODERNATX, INC.-MOD-2021-057948 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Event list is updated. On 14-May-2021: Event information is updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-057948:1st dose case
Fever (to 103F), Encephalopathy (Confusion, somnolent) - improved with resolution of fever (with Tylenol)
arm swollen staring @ time of vax followed by loss of appetite;pt c/o muscles in upper leg from hip to knee sore;visit to MD was given Darvocet & sent to pt unable to tolerate;cont to have severe muscle pain in upper legs;
Severe lower abdominal pain and neutrophilia.  Diagnosed to be a UTI.   Received fluids, iohexol, and nitrofurantoin at hospital.   Sent home same day with prescription for nitrofurantoin (2 times/day for 7 days)
lightheaded and mildly incoherent; lightheaded and mildly incoherent; unable to walk in a straight line; nearly falling over; nauseous; headache; tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Apr2021 14:00 (Lot number: EP7533) at the age of 27 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Past drug history included: Amoxicillin for Known allergies: amoxicillin. The following information was reported: DIZZINESS (non-serious) with onset 16Apr2021 14:30, outcome "recovered" (2021), described as "dizzy"; DIZZINESS (non-serious) with onset 16Apr2021 16:30, outcome "recovered" (2021), INCOHERENT (non-serious) with onset 16Apr2021 14:30, outcome "recovered" (2021) and all described as "lightheaded and mildly incoherent"; WALKING DISABILITY (non-serious) with onset 16Apr2021 14:30, outcome "recovered" (2021), described as "unable to walk in a straight line"; FALL (non-serious) with onset 16Apr2021 14:30, outcome "recovered" (2021), described as "nearly falling over"; NAUSEA (non-serious) with onset 16Apr2021 14:30, outcome "recovered" (2021), described as "nauseous"; HEADACHE (non-serious) with onset 16Apr2021 14:30, outcome "recovered" (2021), described as "headache"; FATIGUE (non-serious) with onset 16Apr2021 14:30, outcome "recovered" (2021), described as "tired". Therapeutic measures were not taken as a result of dizziness, dizziness, incoherent, walking disability, fall, nausea, headache, fatigue.   Clinical course: Within 45 minutes the patient became dizzy, lightheaded and mildly incoherent (as if was under the influence of alcohol). The patient was unable to walk in a straight line without leaning or nearly falling over. The patient had to ask her spouse to pick her up and drive her home. After 2 hours the patient became nauseous with a headache. The dizziness and nausea subsided after 4-5 hours. The patient felt tired but was back to normal by 22:00 (8 hours after receiving the shot). The patient had no side effects the following day. Recurring nausea and mild headache started a week later but resolved within the day.  No follow-up attempts are possible. No further information is expected.
Malaise, swollen lymph nodes in neck and face, facial pain, Temp 99 degrees F, rash.
Sudden loss of hearing; This is a spontaneous report from a contactable consumer.   A 53-year-old male patient received the 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Apr2021 (Batch/Lot number was not reported) as SINGLE DOSE for COVID-19 immunization.  Medical history and concomitant medications were not reported.  On 09Apr2021 (one week after taking the vaccine), the patient experienced sudden loss of hearing. The patient went to the doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care due to the event and received steroids as treatment. The patient was recovering from the event.   No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Multiple canker sores on tongue; Sore throat; Mouth generally swollen; Tired; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old, male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 10:30 (at the age of 29-year-old) as single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Apr2021, at 12:00, the patient experienced multiple canker sores on tongue, sore throat, mouth generally swollen and was tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of multiple canker sores on tongue, sore throat, mouth generally swollen and was tired were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Episodes for months following injection of severe chest pain felt and unable to breath,   dizziness, weakness, and headache with constant ringing in my ears. It's been almost two years and I am still having issues.
I don't believe the adverse reaction was due to the flu shot my mother received but due to the unusual bandaid that was put on the injection site.  It was a circular bandaid that was cushioned on the outer ring and had a clear plastic(?) coating in the center of the bandaid.  It seemed to act like a suction cup drawing the blood up to the surface.  My mother left the bandaid on for 2 days before discovering it and as you can imagine it was very red and it bruised.  This had never happened with any other flu shot but they had never used this kind of bandaid on her before either.  I would let all medical personnel know to never use this type of bandaid, especially on the elderly who have overly sensitive and tender skin in the first place.  There wasn't even any gauze on the bandaid to absorb any drop of blood from the injection.  These bandaids are horrible to use since they cause this type of reaction!  I'd write the company about them but don't know who makes them.  They suck!  Literally!
Transverse myelitis, with symptom onset around 6/22. Symptoms began with bilateral lower extremity weakness and pain, and then progressed to constipation and concomitant bandlike abdominal pain.
Received doses from vials that had been in the refrigerator past the 30 day use by date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received doses from vials that had been in the refrigerator past the 30 day use by date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received doses from vials that had been in the refrigerator past the 30 day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received doses from vials that had been in the refrigerator past the 30 day use by date) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was reported. It was reported that, dosage administered on 13-Oct-2021, 14-Oct-2021 and 19-Oct-2021 from lot 020F21A.   This case was linked to MOD-2021-364962, MOD-2021-364355, MOD-2021-364754, MOD-2021-364515, MOD-2021-364819, MOD-2021-364949, MOD-2021-364896, MOD-2021-365131, MOD-2021-364840, MOD-2021-364950, MOD-2021-365067, MOD-2021-364825, MOD-2021-365177, MOD-2021-365189 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Oct-2021: Follow Up received and added information in narrative
On Saturday morning 23 APR 11 2 days after receiving the ACAM2000 pt. noticed onset of bilateral chest pain accompanied with difficulty breathing, no irregular heartbeat but (+) increased heart rate. No fever, chills, or night sweats. Symptoms have neither increased or decreased in severity.
Fever of at least 101.5; Chills; Body Aches; Injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 19Apr2021 at 16:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to dairy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced fever of at least 101.5, chills, body aches and injection site soreness. On an unknown date in Apr2021, the patient underwent body temperature and the result was 101.5 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of at least 101.5, chills, body aches and injection site soreness was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
DIFFERENT TYPES OF SIDE EFFECTS; This spontaneous report received from a consumer via a company representative concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced different types of side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of different types of side effects was not reported. This report was non-serious. This case, from the same reporter is linked to 20221244677.
?Moderna COVID-19 Vaccine EAU?  Fever and chills for 1 day and sore arms for 3-4 days  Took tylenol for the fever  and cold compress for the sore arms.
** Client asked that name or identifying contact info not be reported in Vaers report 05-21-21 Client called and reported that the morning of 05-06-21 after recieving vaccination on 05-05-21 they started to experience projectile vommiting and profuse diarrhea. Vommiting subsided after approximately 24 hrs  but nausea is still endured. Diarrhea has continud since initial onset but is still observed. Client had a prescription of promethazine readily available but stated it helped very minimally. Consulted PCP who evaluated symptoms and advised to wait on second dose of vaccine due to side effects-
Pt. states that after receiving the 3rd dose of Moderna 12/22/2021, started experiencing symptoms 12/25/2021 pain of the right side of the back side of the head, fatigue, shortness of breath, vertigo, and droopy eyes. Self-treating with Tylenol for pain, no noted Primary visit/communications. Still continuing to experience symptoms.
Severe HSV-2 external to genitalia on buttocks outbreak 2 days after 2nd Covid-19 Pfizer vaccine: multiple lesions along with secondary bacterial infection.
Left knee area swollen, weakness in leg - difficulty walking down steps.   Stiffness after prolonged sitting and feet swelling by end of day
HPV #2 given in (L) deltoid. (HPV #1 given 2/2/2012). Immediately upon removal of the needle from the injection site, there was edema approx 3.0 cm round. Ice applied to site; child c/o tongue "felt funny"; ARNP ordered EPIPEN 0.3mg per 0.3ml and was given SQ (R) thigh; popsicle given; no complications BP immediately following 136/68; 30 mins post BP 124/70.
Information has been received from a registered nurse referring to unspecified number of patients of unknown age and gender. The patients' pertinent medical history and concurrent condition were not reported. The nurse reported that since 29-JUL-2015 the patients had been administered doses of VARIVAX (Merck) (lot# reported as L012036, expiration date 07-APR-2017; Lot#013064, expiration date 14-APR-2017; lot# L009206, expiration date 17-MAR-2017, dose, frequency and route were unknown) which were improperly stored. No adverse effects reported. There were no product quality complaints (PQC) involved. Additional information has been requested.
Pain and sensitivity near right eye and side of head.  Described as "like an electric prod" in the right temporal area and above the right eye.  This has continued intermittently and was present at time of 12/02/13 office visit.  No herpetic rash.  No PH herpetic rash.  No PH of trigeminal neuralgia.